Compound 158
Identifiers
- Canonical SMILES:
CCC[C@H]1CN(CCN1C(=O)C(=O)c1c[nH]c2cccc(F)c12)C(=O)c1ccccc1
- IUPAC name:
1-(4-benzoyl-2-propylpiperazin-1-yl)-2-(4-fluoro-1H-indol-3-yl)ethane-1,2-dione
- InChi:
InChI=1S/C24H24FN3O3/c1-2-7-17-15-27(23(30)16-8-4-3-5-9-16)12-13-28(17)24(31)22(29)18-14-26-20-11-6-10-19(25)21(18)20/h3-6,8-11,14,17,26H,2,7,12-13,15H2,1H3/t17-/m0/s1
- InChiKey:
ATGNIAKOMZKQIA-KRWDZBQOSA-N
External links
45485517 |
24634762 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.81 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 421.18 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 3.68 | |||
TPSA | 73.48 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6928 | Talmapimod | DB05412 | |
0.6642 | LY-517717 | DB05713 | |
0.6488 | Indoramin | DB08950 | |
0.6216 | LTX-315 | DB12748 | |
0.6216 | Gramicidin D | DB00027 | |
0.6133 | TC-6987 | DB14854 | |
0.5987 | Omiganan | DB06610 | |
0.5933 | Macimorelin | DB13074 | |
0.5849 | BQ-123 | DB12054 | |
0.5809 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.5806 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.5776 | Murepavadin | DB14777 | |
0.5769 | Ilomastat | DB02255 | |
0.5753 | Pruvanserin | DB13094 | |
0.5750 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 |